Search bioRxivSearch

bioRxiv · 10.1101/2020.01.10.901470

Serological evidence of Rift Valley fever infection and risk factors among one humped camels (Camelus dromedarius) in Northern Nigeria.

Abstract

BackgroundRift Valley fever (RVF) is a zoonotic disease that has become emerging and re-emerging in some regions of the world, infecting livestock and humans. One-humped camels are important economic livestock species in Africa used for traction, transportation, and food. Regional and international trade has continued to increase the risk of this disease, spreading widely and causing severe economic and public health catastrophes in affected regions. In spite of these risks, there is a dearth of information about the status of RVF in camels in Nigeria. This study was carried out to determine the prevalence of the RVF virus in one-humped camels in Nigeria and identify the risk factors associated with the disease. MethodsA cross-sectional study with simple random sampling was carried out in seven local government areas of Jigawa and Katsina States. The sera from camels were tested for anti-RVFV IgG. Camel owners were administered a structured questionnaire to ascertain their knowledge, attitude, and practice. ResultsAn overall prevalence of 19.9% (95% CI; 17.07-22.90) was recorded. Based on age groups, the highest prevalence of 20.9% (95% CI; 17.00-25.31) was obtained among older camels (6-10 years), while female camels recorded a high prevalence of 20.4% (95%CI; 15.71-25.80). Sule Tankar-kar recorded the highest prevalence with 33% (95%CI; 1.31-4.72, p= 0.007) and OR 2.47 in Jigawa State while Maiadua had 24.7% (95%CI; 0.97-2.73, p=0.030) with OR 1.62 in Katsina State respectively. From the risk map, local government areas bordering Niger Republic were at a high risk of RVF. Only high rainfall was not significantly linked with RVF occurrence among nomadic camel pastoralists (95%CI 0.93-5.20; p=0.070). ConclusionThere is a need for the country to have quarantine units across borders for screening animals coming from neighbouring countries for transboundary infectious diseases such as RVF. Author SummaryRift Valley fever is a viral haemorrhagic fever that affects animals and humans with high mortality. Recently there has been increased demand in camel meat and products for food and therapeutic purposes. Climate change, coupled with insecurity in the Sahel, has had a significant impact on transhumance activities where camels and their owners move to different countries in search of pasture for their animals. Though Nigeria has not reported an outbreak of Rift Valley fever despite serological evidence in various animal species, there is a need to assess RVF in camels, which is a critical animal species, involved in transhumance with the potential of introducing transboundary diseases into new areas. The study assessed the presence of antibodies in camels, identified risk factors associated with the disease in camels and areas at risk for the disease. Our study found a seroprevalence of 19.9% in camels in two northern states of Nigeria, which shares a boundary with the Niger Republic that recently reported an outbreak. Our findings suggest that areas in proximity to Niger Republic are at a high risk to the disease and camels belonging to transhumance pastoralists are highly likely to contract Rift Valley fever since they are exposed to various ecological and environmental factors that precipitate the disease.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Adamu, A. M., Yila, S. A., Allam, L., Sackey, A., Alhaji, N. B., Garba, B. S., Mambula, S. M., Nafarnda, W. D., Idoko, I. S., Balogun, E. O., Owolodun, O. A., Dzikwi, A. A.. 2020-01-10. Serological evidence of Rift Valley fever infection and risk factors among one humped camels (Camelus dromedarius) in Northern Nigeria.. https://doi.org/10.1101/2020.01.10.901470

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology